CRAIGAVON, Northern Ireland and SEATTLE--(BUSINESS WIRE)--March 29, 2006--Almac Diagnostics and Rosetta Biosoftware announced today that Almac Diagnostics (formerly ArraDx Ltd) licensed the Rosetta Resolver(R) system for use in the development of novel microarray-based approaches for diagnosing cancer and predicting therapeutic outcomes. The Resolver system will also be used in the provision of comprehensive gene expression analysis services offered by Almac Diagnostics to academic, biotech and pharmaceutical customers.
